[go: up one dir, main page]

FI964251L - Menetelmä nukleosidianalogien valmistamiseksi diastereoselektiivisesti - Google Patents

Menetelmä nukleosidianalogien valmistamiseksi diastereoselektiivisesti Download PDF

Info

Publication number
FI964251L
FI964251L FI964251A FI964251A FI964251L FI 964251 L FI964251 L FI 964251L FI 964251 A FI964251 A FI 964251A FI 964251 A FI964251 A FI 964251A FI 964251 L FI964251 L FI 964251L
Authority
FI
Finland
Prior art keywords
diastereoselectively
nucleoside analogues
preparing nucleoside
preparing
analogues
Prior art date
Application number
FI964251A
Other languages
English (en)
Swedish (sv)
Other versions
FI964251A0 (fi
FI120401B (fi
Inventor
Michael David Goodyear
P Owen Dwyer
Malcolm Leithead Hill
Andrew Jonathan Whitehead
Roy Hornby
Peter Hallett
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27267157&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI964251(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB9408103A external-priority patent/GB9408103D0/en
Priority claimed from GB9408112A external-priority patent/GB9408112D0/en
Priority claimed from GB9408091A external-priority patent/GB9408091D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI964251L publication Critical patent/FI964251L/fi
Publication of FI964251A0 publication Critical patent/FI964251A0/fi
Application granted granted Critical
Publication of FI120401B publication Critical patent/FI120401B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Treatment Of Water By Oxidation Or Reduction (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI964251A 1994-04-23 1996-10-22 Menetelmä nukleosidianalogien valmistamiseksi diastereoselektiivisesti FI120401B (fi)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB9408103A GB9408103D0 (en) 1994-04-23 1994-04-23 Chemical compounds
GB9408103 1994-04-23
GB9408112A GB9408112D0 (en) 1994-04-23 1994-04-23 Process
GB9408091 1994-04-23
GB9408091A GB9408091D0 (en) 1994-04-23 1994-04-23 Process
GB9408112 1994-04-23
PCT/EP1995/001503 WO1995029174A1 (en) 1994-04-23 1995-04-21 Process for the diastereoselective synthesis of nucleoside analogues
EP9501503 1995-04-21

Publications (3)

Publication Number Publication Date
FI964251L true FI964251L (fi) 1996-10-22
FI964251A0 FI964251A0 (fi) 1996-10-22
FI120401B FI120401B (fi) 2009-10-15

Family

ID=27267157

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964251A FI120401B (fi) 1994-04-23 1996-10-22 Menetelmä nukleosidianalogien valmistamiseksi diastereoselektiivisesti

Country Status (30)

Country Link
US (2) US6051709A (fi)
EP (1) EP0757684B1 (fi)
JP (2) JP4056558B2 (fi)
KR (1) KR100241842B1 (fi)
CN (2) CN1290841C (fi)
AP (1) AP704A (fi)
AT (1) ATE181326T1 (fi)
AU (1) AU696612B2 (fi)
BG (1) BG62810B1 (fi)
BR (1) BR9507499A (fi)
CZ (1) CZ293827B6 (fi)
DE (1) DE69510347T2 (fi)
DK (1) DK0757684T3 (fi)
EE (1) EE03442B1 (fi)
ES (1) ES2133769T3 (fi)
FI (1) FI120401B (fi)
GR (1) GR3031043T3 (fi)
HK (1) HK1004221A1 (fi)
HU (1) HU218044B (fi)
IL (1) IL113432A (fi)
IS (1) IS1844B (fi)
NO (2) NO307179B1 (fi)
NZ (1) NZ285396A (fi)
PL (1) PL180090B1 (fi)
RO (2) RO118714B1 (fi)
RU (1) RU2158736C2 (fi)
SK (1) SK281327B6 (fi)
TW (1) TW487704B (fi)
UA (1) UA43362C2 (fi)
WO (1) WO1995029174A1 (fi)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5684164A (en) * 1988-04-11 1997-11-04 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
IL113432A (en) * 1994-04-23 2000-11-21 Glaxo Group Ltd Process for the diastereoselective synthesis of nucleoside analogues
AU3710395A (en) * 1994-10-22 1996-05-15 Chong Kun Dang Corporation Nucleoside derivatives and process for preparing thereof
GB9506644D0 (en) * 1995-03-31 1995-05-24 Wellcome Found Preparation of nucleoside analogues
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
IL141359A0 (en) * 1998-08-12 2002-03-10 Triangle Pharmaceuticals Inc Method of manufacture of 1,3-oxathiolane nucleosides
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
US6432966B2 (en) 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
EP1903041B1 (en) 2001-03-01 2015-02-18 AbbVie Inc. Polymorphic and other crystalline forms of cis-FTC
CA2351049C (en) 2001-06-18 2007-03-13 Brantford Chemicals Inc. Process for recovery of the desired cis-1,3-oxathiolane nucleosides from their undesired trans-isomers
WO2003027106A1 (en) * 2001-09-25 2003-04-03 Cadila Healthcar Limited Process for the preparation of crystalline polymorph ii of lamivudine
ITMI20030578A1 (it) * 2003-03-24 2004-09-25 Clariant Lsm Italia Spa Processo ed intermedi per la preparazione di emtricitabina
US20050187913A1 (en) 2003-05-06 2005-08-25 Yoram Nelken Web-based customer service interface
CN101307048B (zh) 2007-05-18 2011-03-23 上海迪赛诺医药发展有限公司 立体选择性制备拉米夫定的方法
US20100190982A1 (en) * 2007-09-17 2010-07-29 Janardhana Rao Vascuri Process for the preparation of lamivudine form i
EP2048151A1 (en) * 2007-10-10 2009-04-15 Cilag AG Method for producing nucleosides by direct glycosylation of the nucleoside base
EP2225232B1 (en) 2007-11-29 2012-09-26 Ranbaxy Laboratories Limited Process for the preparation of substituted 1,3-oxathiolanes
AU2008331168A1 (en) * 2007-11-29 2009-06-04 Ranbaxy Laboratories Limited Crystalline form I of lamivudine and its preparation
CN101918416A (zh) * 2007-11-29 2010-12-15 兰贝克赛实验室有限公司 制备取代的1,3-氧硫杂环戊烷,尤其是拉米夫定的方法和中间体
WO2009084033A2 (en) * 2007-12-07 2009-07-09 Matrix Laboratories Limited Process for producing 5-fluoro-1-(2r,5s)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yi]cytosine
CN101362752B (zh) * 2008-09-18 2011-12-28 浙江教育学院 一种拉米夫定中间体的合成方法
CN101391997B (zh) * 2008-09-18 2010-12-22 江苏科本医药化学有限公司 一种恩曲他滨中间体的合成方法
US20110282046A1 (en) 2009-01-19 2011-11-17 Rama Shankar Process for preparation of cis-nucleoside derivative
KR101474570B1 (ko) 2009-04-13 2014-12-19 주식회사 대희화학 라미부딘의 신규한 중간체 및 이의 제조방법
CN101544632B (zh) * 2009-04-24 2011-09-07 湖南千金湘江药业股份有限公司 拉米夫定非对映选择合成方法
ES2540074T3 (es) 2009-10-14 2015-07-08 Mylan Laboratories Limited Proceso para la preparación de lamivudina y nuevas sales en la fabricación de la misma
KR101830715B1 (ko) 2010-01-27 2018-04-04 비이브 헬쓰케어 컴퍼니 Hiv 감염을 치료하기 위한 약학적 조합물
WO2011095987A1 (en) 2010-02-03 2011-08-11 Matrix Laboratories Ltd. Novel process for the preparation of cis-nucleoside derivative
CN102167696B (zh) 2010-02-25 2013-09-18 南京正大天晴制药有限公司 拉米夫定草酸盐及其制备方法
AU2011222471B2 (en) * 2010-03-04 2014-07-31 Sun Pharmaceutical Industries Limited A process for stereoselective synthesis of 5-fluoro-1-(2R,5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
CN101830893A (zh) * 2010-05-31 2010-09-15 安徽一帆香料有限公司 一种拉米夫定中间体hdms的合成制备工艺
CN102399213A (zh) * 2010-09-08 2012-04-04 重庆医药工业研究院有限责任公司 拉米夫定单邻苯二甲酸盐及其合成方法
CN103221037A (zh) 2010-11-12 2013-07-24 葛兰素惠尔康制造业私人有限公司 新药物组合物
ES2729824T3 (es) 2011-04-08 2019-11-06 Laurus Labs Ltd Formas sólidas de compuestos antirretrovirales, procedimiento para la preparación y composición farmacéutica de los mismos
CN102796088B (zh) * 2012-05-21 2015-06-10 湖南千金湘江药业股份有限公司 一种拉米夫定的制备方法
CN103450166A (zh) * 2012-05-31 2013-12-18 上海迪赛诺药业有限公司 制备核苷化合物的方法
CN103864835A (zh) * 2013-03-26 2014-06-18 安徽贝克联合制药有限公司 一种提高拉米夫定中间体立体选择性制备方法
CN103288806A (zh) * 2013-07-02 2013-09-11 山东大学 一种曲沙他滨的合成方法
CN103694231A (zh) * 2013-11-28 2014-04-02 安徽一帆香料有限公司 一种拉米夫定中间体hdms的合成制备方法
US9571109B2 (en) * 2015-03-27 2017-02-14 International Business Machines Corporation Voltage controlled oscillator runaway prevention
CN106146481A (zh) * 2015-04-07 2016-11-23 江苏普信制药有限公司 一种核苷类似物的制备方法
CN105037340B (zh) * 2015-07-14 2018-08-10 福建广生堂药业股份有限公司 一种拉米夫定关键中间体手性异构体杂质的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466806A (en) * 1989-02-08 1995-11-14 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
US5684164A (en) * 1988-04-11 1997-11-04 Biochem Pharma Inc. Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
AU3154993A (en) * 1989-02-08 1994-07-19 Biochem Pharma Inc. Process for preparing substituted 1,3-oxathiolanes with antiviral properties
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
US5587480A (en) * 1990-11-13 1996-12-24 Biochem Pharma, Inc. Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
DE69206876T3 (de) 1991-05-16 2004-08-12 Glaxo Group Ltd., Greenford Nukleosidanalogen enthaltende Antiviren-Zubereitungen
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923640B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9116601D0 (en) * 1991-08-01 1991-09-18 Iaf Biochem Int 1,3-oxathiolane nucleoside analogues
IL113432A (en) * 1994-04-23 2000-11-21 Glaxo Group Ltd Process for the diastereoselective synthesis of nucleoside analogues

Also Published As

Publication number Publication date
CN1500782A (zh) 2004-06-02
US6329522B1 (en) 2001-12-11
DK0757684T3 (da) 2000-01-17
IS1844B (is) 2003-01-30
EE9600134A (et) 1997-04-15
CZ293827B6 (cs) 2004-08-18
UA43362C2 (uk) 2001-12-17
RO117916B1 (ro) 2002-09-30
NO307179B1 (no) 2000-02-21
CN1151146C (zh) 2004-05-26
NO964487L (no) 1996-12-17
IL113432A (en) 2000-11-21
FI964251A0 (fi) 1996-10-22
BR9507499A (pt) 1997-09-23
NZ285396A (en) 1998-10-28
US6051709A (en) 2000-04-18
ATE181326T1 (de) 1999-07-15
JPH10502615A (ja) 1998-03-10
CN1149871A (zh) 1997-05-14
JP4056558B2 (ja) 2008-03-05
RU2158736C2 (ru) 2000-11-10
PL180090B1 (pl) 2000-12-29
BG62810B1 (bg) 2000-08-31
RO118714B1 (ro) 2003-09-30
AU696612B2 (en) 1998-09-17
PL316904A1 (en) 1997-02-17
TW487704B (en) 2002-05-21
IL113432A0 (en) 1995-07-31
HU9602925D0 (en) 1996-12-30
JP2007217425A (ja) 2007-08-30
AU2447195A (en) 1995-11-16
NO964487D0 (no) 1996-10-22
WO1995029174A1 (en) 1995-11-02
HU218044B (hu) 2000-05-28
AP704A (en) 1998-12-04
EP0757684A1 (en) 1997-02-12
HUT76296A (en) 1997-07-28
FI120401B (fi) 2009-10-15
IS4366A (is) 1996-09-27
EP0757684B1 (en) 1999-06-16
SK281327B6 (sk) 2001-02-12
HK1004221A1 (en) 1998-11-20
DE69510347D1 (de) 1999-07-22
EE03442B1 (et) 2001-06-15
BG100916A (en) 1997-07-31
NO995646L (no) 1999-11-17
ES2133769T3 (es) 1999-09-16
DE69510347T2 (de) 1999-11-18
SK135596A3 (en) 1997-07-09
CZ309696A3 (en) 1997-04-16
KR100241842B1 (ko) 2000-03-02
NO995646D0 (no) 1999-11-17
CN1290841C (zh) 2006-12-20
AP9600871A0 (en) 1996-10-31
NO313096B1 (no) 2002-08-12
GR3031043T3 (en) 1999-12-31

Similar Documents

Publication Publication Date Title
FI964251L (fi) Menetelmä nukleosidianalogien valmistamiseksi diastereoselektiivisesti
FI951596L (fi) Menetelmä 10-desasetyylibakkatiini-III:n saamiseksi
FI962069L (fi) Menetelmä karpolaktaamin valmistamiseksi
FI991477L (fi) Menetelmä tolterodiinin valmistamiseksi
FI951780L (fi) Menetelmä katalyyttikomponenttien valmistamiseksi
FI951590L (fi) Menetelmä 10-desasetyylibakkatiini III:n valmistamiseksi
DE69505587D1 (de) Landungshilfevorrichtung
DE69518503D1 (de) Verbessertes rtm verfahren
FI965268A0 (fi) Menetelmä moniarvoisten alkoholien valmistamiseksi
AR017655A1 (es) Metodo para preparar eteres de monofluormetilo
KR970001365A (ko) 알킬하이드로겐클로로실란의 제조방법
FI890286L (fi) Menetelmä terapeuttisesti käyttökelpoisten dideoksikarbosyklisten nukleosidianalogien valmistamiseksi
FI891711L (fi) Menetelmä diorganodialkoksisilaanien valmistamiseksi
FI951903L (fi) Menetelmä gingkolidi B:n valmistamiseksi ginkgolidi C:stä
FI963344L (fi) Menetelmä substituoitujen tiatsolien valmistamiseksi
FI972720A0 (fi) Menetelmä lamotrigiinin valmistamiseksi
FI955800L (fi) Menetelmä aminoalkyyliganidiinien valmistamiseksi
FI931850L (fi) Menetelmä välituotteen valmistamiseksi
FI963452L (fi) Menetelmä epoxidin valmistamiseksi
FI964001L (fi) Menetelmä 7-trialkyylisilyylibakkatiini III:n valmistamiseksi
FI942102L (fi) Menetelmä alumiinioksaanien valmistamiseksi
FI961827L (fi) Menetelmä 1,3-diolien monoesterien valmistamiseksi
FI972314L (fi) Menetelmä kaprolaktaamin valmistamiseksi
FI963018L (fi) Menetelmä gammapyronien valmistamiseksi
DE69024139D1 (de) Fixiermethode

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120401

Country of ref document: FI

MA Patent expired